Xuedong Li

1.2k total citations
45 papers, 736 citations indexed

About

Xuedong Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xuedong Li has authored 45 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Xuedong Li's work include Ferroptosis and cancer prognosis (8 papers), Renal cell carcinoma treatment (5 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Xuedong Li is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Renal cell carcinoma treatment (5 papers) and Kidney Stones and Urolithiasis Treatments (4 papers). Xuedong Li collaborates with scholars based in China, Türkiye and United States. Xuedong Li's co-authors include Hongyan Zhang, Chun Chen, Jianjun Zhao, Zhengxiang Zhang, Xiaoyi Guo, Bosen You, Guangmin Cong, Wenfu Zhang, Mingcai Chen and Yuhui Huang and has published in prestigious journals such as PLoS ONE, Oncogene and The Journal of Urology.

In The Last Decade

Xuedong Li

42 papers receiving 728 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xuedong Li 265 160 147 96 79 45 736
Linling Chen 332 1.3× 65 0.4× 118 0.8× 77 0.8× 12 0.2× 49 764
Jiang Zhu 310 1.2× 258 1.6× 111 0.8× 278 2.9× 29 0.4× 98 1.1k
Gregory E. Holt 238 0.9× 225 1.4× 78 0.5× 260 2.7× 9 0.1× 42 1.0k
Yongmei Liu 277 1.0× 230 1.4× 55 0.4× 165 1.7× 26 0.3× 53 1.1k
Yiyang Li 218 0.8× 38 0.2× 94 0.6× 59 0.6× 20 0.3× 62 804
Xuepei Zhang 357 1.3× 198 1.2× 225 1.5× 110 1.1× 12 0.2× 70 778
Jongchan Kim 220 0.8× 270 1.7× 65 0.4× 91 0.9× 12 0.2× 85 1.2k
Liqun Wang 197 0.7× 380 2.4× 98 0.7× 53 0.6× 32 0.4× 38 1.1k
Xiaoyu Zhou 542 2.0× 56 0.3× 194 1.3× 61 0.6× 64 0.8× 72 1.0k
Chunyan Peng 311 1.2× 52 0.3× 115 0.8× 88 0.9× 88 1.1× 45 813

Countries citing papers authored by Xuedong Li

Since Specialization
Citations

This map shows the geographic impact of Xuedong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuedong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuedong Li more than expected).

Fields of papers citing papers by Xuedong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuedong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuedong Li. The network helps show where Xuedong Li may publish in the future.

Co-authorship network of co-authors of Xuedong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xuedong Li. A scholar is included among the top collaborators of Xuedong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuedong Li. Xuedong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Bo, Weiyang Liu, Wan‐Hui Wang, et al.. (2025). CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis. Frontiers in Immunology. 16. 1619361–1619361.
2.
Xu, Haitao, Qiuqi Zhang, Ying Xu, et al.. (2025). CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancer. Cell Biology and Toxicology. 41(1). 61–61. 1 indexed citations
3.
Zhou, Cheng, Yong Zhang, Dan Yin, et al.. (2025). FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion. Cell & Bioscience. 15(1). 58–58. 3 indexed citations
4.
5.
Li, Xuedong, et al.. (2024). DifFilter: Defending Against Adversarial Perturbations With Diffusion Filter. IEEE Transactions on Information Forensics and Security. 19. 6779–6794. 4 indexed citations
6.
Sun, Yanan, Rongfang Wang, Yuxin Zhou, et al.. (2024). Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy. Cancer Medicine. 13(13). e7453–e7453. 3 indexed citations
7.
Zhang, Wei, Zhuolun Li, Qing Liu, et al.. (2024). Downregulation of UBB potentiates SP1/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma. Oncogene. 43(18). 1386–1396. 6 indexed citations
8.
Liu, Weiyang, et al.. (2024). Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC. Cell Death and Disease. 15(8). 613–613. 3 indexed citations
9.
Liu, Weiyang, Wei Zhang, Zhuolun Li, et al.. (2023). The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features. Frontiers in Pharmacology. 14. 1333507–1333507. 2 indexed citations
10.
Liu, Qing, Hongyang Yu, Xinyang He, et al.. (2022). Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry. Cell Death and Disease. 13(4). 382–382. 52 indexed citations
11.
Li, Xuedong, et al.. (2022). Identification of a Five-miRNA Signature for Diagnosis of Kidney Renal Clear Cell Carcinoma. Frontiers in Genetics. 13. 857411–857411. 4 indexed citations
12.
Wu, Pengfei, Qun Chen, Jiang Liu, et al.. (2020). Tumor Cell–Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA. Cancer Immunology Research. 8(12). 1470–1484. 35 indexed citations
13.
Li, Lihong, et al.. (2019). Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma. Journal of Translational Medicine. 17(1). 177–177. 18 indexed citations
14.
Li, Xuedong, et al.. (2019). Improving rare disease classification using imperfect knowledge graph. BMC Medical Informatics and Decision Making. 19(S5). 238–238. 23 indexed citations
15.
Zhang, Hongqiao, et al.. (2018). Environmental Regulation, Technological Innovation and Sustainable Growth. 1 indexed citations
16.
Zhao, Jianjun, Hongyan Zhang, Zhengxiang Zhang, et al.. (2015). Spatial and Temporal Changes in Vegetation Phenology at Middle and High Latitudes of the Northern Hemisphere over the Past Three Decades. Remote Sensing. 7(8). 10973–10995. 106 indexed citations
17.
Zhang, Chunying, et al.. (2015). The Change of Semen Superoxide Dismutase and Acrosin Activity in the Sterility of Male Patients with Positive Antisperm Antibody. Cell Biochemistry and Biophysics. 73(2). 451–453. 3 indexed citations
18.
Xu, Yangyang, et al.. (2014). Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1. Molecular Medicine Reports. 11(4). 2717–2722. 7 indexed citations
19.
Zhang, Wenji, Xuedong Li, Tiantian Ye, et al.. (2013). Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. International Journal of Pharmaceutics. 454(1). 354–366. 76 indexed citations
20.
Huo, Kaifu, Boquan Zhu, Jijiang Fu, Xuedong Li, & Paul K. Chu. (2010). Large-Scale Synthesis of Mullite Nanowires by Molten Salt Method. Journal of Nanoscience and Nanotechnology. 10(7). 4792–4796. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linling Chen Breakdown of academic impact, for papers by Jiang Zhu Breakdown of academic impact, for papers by Gregory E. Holt Breakdown of academic impact, for papers by Yongmei Liu Breakdown of academic impact, for papers by Yiyang Li Breakdown of academic impact, for papers by Xuepei Zhang Breakdown of academic impact, for papers by Jongchan Kim Breakdown of academic impact, for papers by Liqun Wang Breakdown of academic impact, for papers by Xiaoyu Zhou Breakdown of academic impact, for papers by Chunyan Peng
Rankless by CCL
2026